Logo image of ARWR

ARROWHEAD PHARMACEUTICALS IN (ARWR) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:ARWR - US04280A1007 - Common Stock

65.58 USD
-1.33 (-1.99%)
Last: 1/28/2026, 8:00:01 PM
65.63 USD
+0.05 (+0.08%)
After Hours: 1/28/2026, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ARWR revenue by date.ARWR revenue by date.
240.7M
-1.03%
3.551M
-98.52%
829.448M
23,258.15%
410.29M
-50.53%
277.18M
-32.44%
506.97M
82.90%
852.77M
68.21%
1.539B
80.47%
1.881B
22.22%
2.571B
36.68%
3.224B
25.40%
EBITDA
YoY % growth
ARWR ebitda by date.ARWR ebitda by date.
-192.5M
-14.52%
-582.485M
-202.59%
122.274M
120.99%
-284.77M
-332.89%
-669.776M
-135.20%
-633.199M
5.46%
-183.6M
71.00%
489.5M
366.61%
1.006B
105.52%
N/AN/A
EBIT
YoY % growth
ARWR ebit by date.ARWR ebit by date.
-205M
-14.85%
-601.08M
-193.21%
98.346M
116.36%
-411.932M
-518.86%
-624.106M
-51.51%
-471.078M
24.52%
-160.191M
65.99%
478.52M
398.72%
735.15M
53.63%
1.22B
65.95%
1.767B
44.84%
Operating Margin
ARWR operating margin by date.ARWR operating margin by date.
-85.17%-16,927.06%11.86%-100.40%-225.16%-92.92%-18.78%31.09%39.08%47.45%54.81%
EPS
YoY % growth
ARWR eps by date.ARWR eps by date.
-1.92
-14.29%
-5.01
-160.94%
-0.08
98.40%
-3.43
-4,191.43%
-4.70
-36.79%
-3.43
26.90%
-1.53
55.44%
3.46
326.33%
4.70
35.79%
8.49
80.48%
12.65
49.12%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
0.26
118.57%
-1.12
-140.87%
-1.33
-5.48%
-1.37
-659.33%
-1.19
-562.45%
-1.32
-17.06%
-1.34
-0.54%
-0.87
36.19%
Revenue
Q2Q % growth
275.47M
10,918.80%
70.096M
-87.09%
41.623M
49.90%
44.877M
-82.50%
57.579M
-79.10%
40.545M
-42.16%
43.146M
3.66%
135.41M
201.74%
EBITDA
Q2Q % growth
227.08M
245.40%
-147.331M
-137.53%
-187.078M
-26.40%
-201.79M
-396.60%
N/AN/AN/AN/A
EBIT
Q2Q % growth
106.62M
166.05%
-162.943M
-142.74%
-175.521M
-6.02%
-188.466M
-527.30%
-168.888M
-258.40%
-171.135M
-5.03%
-167.451M
4.60%
-170.018M
9.79%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2025
Q2Q % growth
-0.18
86.86%
-0.250.0726.70%
Q3 2025
Q2Q % growth
-1.26
8.70%
-1.05-0.21-20.51%
Q2 2025
Q2Q % growth
2.75
369.61%
-0.202.951,461.66%
Q1 2025
Q2Q % growth
-1.39
-12.10%
-0.45-0.94-211.36%
Q4 2024
Q2Q % growth
-1.37
-34.31%
-1.07-0.30-28.19%
Q3 2024
Q2Q % growth
-1.38
-43.75%
-0.56-0.82-145.24%
Q2 2024
Q2Q % growth
-1.02
-326.67%
-0.17-0.85-515.69%
Q1 2024
Q2Q % growth
-1.24
-217.95%
-0.84-0.40-48.25%
Q4 2023
Q2Q % growth
-1.02
-25.93%
-0.62-0.40-65.77%
Q3 2023
Q2Q % growth
-0.96
-41.18%
-0.67-0.29-44.13%
Q2 2023
Q2Q % growth
0.45
9.76%
-0.651.10168.84%
Q1 2023
Q2Q % growth
-0.39
35.00%
0.45-0.84-187.62%
Q4 2022
Q2Q % growth
-0.81
-32.79%
-0.17-0.64-379.95%
Q3 2022
Q2Q % growth
-0.68
-134.48%
-0.52-0.16-31.80%
Q2 2022
Q2Q % growth
0.41
257.69%
-0.080.49596.25%
Q1 2022
Q2Q % growth
-0.60
-200.00%
-0.46-0.14-31.60%
Q4 2021
Q2Q % growth
-0.61
-27.08%
-0.11-0.50-467.08%
Q3 2021
Q2Q % growth
-0.29
-123.08%
-0.20-0.09-44.10%
Q2 2021
Q2Q % growth
-0.26
-30.00%
-0.13-0.13-94.14%
Q1 2021
Q2Q % growth
-0.20
-566.67%
0.12-0.32-266.32%
Q4 2020
Q2Q % growth
-0.48 0.12-0.60-504.42%
Q3 2020
Q2Q % growth
-0.13 -0.12-0.01-9.87%
Q2 2020
Q2Q % growth
-0.20 -0.11-0.09-80.07%
Q1 2020
Q2Q % growth
-0.03 -0.01-0.02-311.93%
ARWR Yearly EPS VS EstimatesARWR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 5 -5 10
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2025
Q2Q % growth
256.472M 179.38M77.092M42.98%
Q3 2025
Q2Q % growth
27.767M 24.185M3.582M14.81%
Q2 2025
Q2Q % growth
543M 30.504M512.496M1,680.09%
Q1 2025
Q2Q % growth
2.5M
-29.60%
74.205M-71.705M-96.63%
Q4 2024
Q2Q % growth

-100.00%
65.099M-65.099M-100.00%
Q3 2024
Q2Q % growth

-100.00%
53.688M-53.688M-100.00%
Q2 2024
Q2Q % growth

-100.00%
65.147M-65.147M-100.00%
Q1 2024
Q2Q % growth
3.551M
-94.32%
30.101M-26.55M-88.20%
Q4 2023
Q2Q % growth
16.097M
-49.06%
51.743M-35.646M-68.89%
Q3 2023
Q2Q % growth
15.825M
-51.16%
50.169M-34.344M-68.46%
Q2 2023
Q2Q % growth
146.267M
-3.64%
46.389M99.878M215.31%
Q1 2023
Q2Q % growth
62.5M
128.10%
165.77M-103.27M-62.30%
Q4 2022
Q2Q % growth
31.6M
-17.49%
51.453M-19.853M-38.58%
Q3 2022
Q2Q % growth
32.4M
-29.41%
56.332M-23.932M-42.48%
Q2 2022
Q2Q % growth
151.8M
362.80%
111.09M40.71M36.65%
Q1 2022
Q2Q % growth
27.4M
28.64%
52.065M-24.665M-47.37%
Q4 2021
Q2Q % growth
38.3M
403.95%
57.91M-19.61M-33.86%
Q3 2021
Q2Q % growth
45.9M
67.52%
38.267M7.633M19.95%
Q2 2021
Q2Q % growth
32.8M
39.57%
38.451M-5.651M-14.70%
Q1 2021
Q2Q % growth
21.3M
-27.80%
77.076M-55.776M-72.36%
Q4 2020
Q2Q % growth
7.6M 50.227M-42.627M-84.87%
Q3 2020
Q2Q % growth
27.4M 29.49M-2.09M-7.09%
Q2 2020
Q2Q % growth
23.5M 22.175M1.325M5.98%
Q1 2020
Q2Q % growth
29.5M 30.09M-590K-1.96%
ARWR Yearly Revenue VS EstimatesARWR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-3.07% -25.95% -4.21% -17.77%
Revenue0% -6.41% -3.44% 2.9%